Science Explorer Back to mapMap
Discussion
Researcher · Ragon Institute of MGH, MIT and Harvard · United States

Mathias D. Lichterfeld

Mathias D. Lichterfeld publishes mostly in Immunology, Virology and Infectious Diseases, on topics such as HIV Research and Treatment, Immune Cell Function and Interaction and HIV/AIDS drug development and treatment.

ORCID 0000-0001-9865-8350 OpenAlex
World rank
#69,460
of 7,710,434 ranked researchers
Rank in United States
#26,833
of 1,627,098
Works
255
Citations
17k
Citations per work
65.5
h-index
62
i10-index 154Top 2.3% in Immunology
Mathias D. Lichterfeld

What does Mathias D. Lichterfeld research?

Mathias D. Lichterfeld's work is mostly in Immunology and Microbiology (57%), Medicine (30%), Biochemistry, Genetics and Molecular Biology (2%).

Life Sciences: 152 works · 59.5% of their workImmunology and Microbiology: 146 works · 57.3% of their workImmunology: 75 works · 29.4% of their workVirology: 71 works · 27.9% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 2.2% of their workMolecular Biology: 6 works · 2.2% of their workHealth Sciences: 76 works · 29.7% of their workMedicine: 76 works · 29.7% of their workInfectious Diseases: 57 works · 22.3% of their workEpidemiology: 12 works · 4.9% of their workEmergency Medicine: 6 works · 2.5% of their workEverything else: 28 works · 10.8% of their workTHEIR WORKMathias D.Lichterfeld255works
Life Sciences60%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology14657.3%
    2. Biochemistry, Genetics and Molecular Biology62.2%
    1. Medicine7629.7%
  3. Everything else2810.8%
  1. 1Immunology29% of their works
  2. 2Virology28% of their works
  3. 3Infectious Diseases22% of their works
  4. 4Epidemiology5% of their works
  5. 5Emergency Medicine2% of their works
  6. 6Molecular Biology2% of their works

Research topics

Which keywords describe Mathias D. Lichterfeld's research?

The keywords of their largest research topics: Antiretroviral Therapy, AIDS, HIV, Natural Killer Cells, NK Cell Recognition, HIV Infection, Drug Resistance and Integrase Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Antiretroviral Therapy3394 topics
  2. AIDS1921 topic
  3. HIV1921 topic
  4. NK Cell Recognition1021 topic
  5. Natural Killer Cells1021 topic
  6. HIV Infection872 topics
  7. Drug Resistance711 topic
  8. Integrase Inhibitors711 topic
  9. HIV Transmission601 topic
  10. Preexposure Prophylaxis601 topic
  11. Foxp3531 topic
  12. TGF-ß531 topic
  13. Cytomegalovirus201 topic
  14. Infection201 topic
  15. Dendritic Cells181 topic
  16. Immunity181 topic
  17. Cardiovascular Disease161 topic
  18. Inflammation161 topic

Where does Mathias D. Lichterfeld work?

Mathias D. Lichterfeld's main affiliation in the publication record is Ragon Institute of MGH, MIT and Harvard, United States.

How many publications and citations does Mathias D. Lichterfeld have?

OpenAlex counts 255 works and 16,695 citations for Mathias D. Lichterfeld, an h-index of 62, ranking #69,460 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mathias D. Lichterfeld. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.